MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ohn.70400

Медицинская библиотека · Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026

The Diagnostic Performance of Afirma Genomic Sequencing Classifier in Black and Hispanic Patients With Indeterminate Thyroid Nodules.

Attia Peter J, Chinta Sree, Celidonio Joseph, Armas John Sebastian De, Kalyoussef Evelyne, Roden Dylan F

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

About 20% of thyroid nodules detected on ultrasound are cytologically indeterminate (Bethesda categories III and IV), but the rate of malignancy of these nodules is less than 36%. The ability of Afirma Genomic Sequencing Classifier (GSC) to further risk-stratify indeterminate thyroid nodules among Black and Hispanic patients is understudied.

STUDY

DESIGN

Retrospective Chart Review.

SETTING

Two Academic Medical Centers.

METHODS

Black and Hispanic patients who underwent Afirma GSC from 2017 to 2024 were included. Demographics, clinical history, GSC results, and surgical pathology reports were captured. Univariate analysis was conducted to elucidate demographic and clinical characteristics of this population, and confusion matrices evaluated GSC test performance.

RESULTS

160 patients were included in this cohort with a median age at diagnosis of 51 years, 142 (88.8%) females, 86 (53.8%) Black, and 74 (46.2%) Hispanic. Median nodule size was 2.4 cm, 167 were Bethesda III, and 17 were Bethesda IV. Of the 184 Bethesda III and IV thyroid nodules tested with GSC, 131 (71.2%) were reported as benign. In total, 59 nodules (29.4%) were resected, with 19 malignancies. The observed values of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 89.5%, 78.2%, 32.1%, and 98.5%. For all specimens with oncocytic cytology (n = 45), the sensitivity, specificity, PPV, and NPV were 83.3%, 69.2%, 29.4%, and 96.4%, respectively.

CONCLUSIONS

This represents the largest study of Afirma GSC involving Black and Hispanic patients. In this cohort, the diagnostic performance of the Afirma GSC was comparable to that observed in the original validation study.

Для цитирования: Attia Peter J, Chinta Sree, Celidonio Joseph, Armas John Sebastian De, Kalyoussef Evelyne, Roden Dylan F. The Diagnostic Performance of Afirma Genomic Sequencing Classifier in Black and Hispanic Patients With Indeterminate Thyroid Nodules.. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2026. DOI: 10.1002/ohn.70400.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.